PortfoliosLab logo
Tools
Performance Analysis
Risk Analysis
Optimization
Factor Model
See All Tools
Portfolio Analysis
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
ShockWave Medical, Inc. (SWAV)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISINUS82489T1043
CUSIP82489T104
SectorHealthcare
IndustryMedical Devices

Highlights

Market Cap$12.34B
EPS$3.85
PE Ratio85.45
Revenue (TTM)$730.23M
Gross Profit (TTM)$424.74M
EBITDA (TTM)$176.35M
Year Range$157.00 - $331.58
Target Price$316.14
Short %7.07%
Short Ratio2.97

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


ShockWave Medical, Inc.

Popular comparisons: SWAV vs. DOCS, SWAV vs. MNHYX, SWAV vs. MEDP, SWAV vs. SITE, SWAV vs. VOO, SWAV vs. SPY, SWAV vs. COST, SWAV vs. AAPL, SWAV vs. IWM, SWAV vs. NVDA

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in ShockWave Medical, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


0.00%200.00%400.00%600.00%800.00%1,000.00%NovemberDecember2024FebruaryMarchApril
1,018.63%
83.65%
SWAV (ShockWave Medical, Inc.)
Benchmark (^GSPC)

S&P 500

Returns By Period

ShockWave Medical, Inc. had a return of 72.64% year-to-date (YTD) and 15.30% in the last 12 months.


PeriodReturnBenchmark
Year-To-Date72.64%5.84%
1 month4.09%-2.98%
6 months59.46%22.02%
1 year15.30%24.47%
5 years (annualized)51.51%11.44%
10 years (annualized)N/A10.46%

Monthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
202418.73%15.30%24.82%
2023-9.66%3.60%-15.37%9.17%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of SWAV is 60, suggesting that the investment has average results relative to the market in terms of risk-adjusted performance. This ranking is determined by the cumulative values of the indicators listed below.

The Risk-Adjusted Performance Rank of SWAV is 6060
ShockWave Medical, Inc.(SWAV)
The Sharpe Ratio Rank of SWAV is 6262Sharpe Ratio Rank
The Sortino Ratio Rank of SWAV is 5858Sortino Ratio Rank
The Omega Ratio Rank of SWAV is 6060Omega Ratio Rank
The Calmar Ratio Rank of SWAV is 6565Calmar Ratio Rank
The Martin Ratio Rank of SWAV is 5757Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for ShockWave Medical, Inc. (SWAV) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


SWAV
Sharpe ratio
The chart of Sharpe ratio for SWAV, currently valued at 0.38, compared to the broader market-2.00-1.000.001.002.003.004.000.38
Sortino ratio
The chart of Sortino ratio for SWAV, currently valued at 0.81, compared to the broader market-4.00-2.000.002.004.006.000.81
Omega ratio
The chart of Omega ratio for SWAV, currently valued at 1.11, compared to the broader market0.501.001.501.11
Calmar ratio
The chart of Calmar ratio for SWAV, currently valued at 0.35, compared to the broader market0.002.004.006.000.35
Martin ratio
The chart of Martin ratio for SWAV, currently valued at 0.69, compared to the broader market0.0010.0020.0030.000.69
^GSPC
Sharpe ratio
The chart of Sharpe ratio for ^GSPC, currently valued at 2.05, compared to the broader market-2.00-1.000.001.002.003.004.002.05
Sortino ratio
The chart of Sortino ratio for ^GSPC, currently valued at 2.98, compared to the broader market-4.00-2.000.002.004.006.002.98
Omega ratio
The chart of Omega ratio for ^GSPC, currently valued at 1.36, compared to the broader market0.501.001.501.36
Calmar ratio
The chart of Calmar ratio for ^GSPC, currently valued at 1.55, compared to the broader market0.002.004.006.001.55
Martin ratio
The chart of Martin ratio for ^GSPC, currently valued at 8.05, compared to the broader market0.0010.0020.0030.008.05

Sharpe Ratio

The current ShockWave Medical, Inc. Sharpe ratio is 0.38. A Sharpe ratio between 0 and 1.0 is considered sub-optimal.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00NovemberDecember2024FebruaryMarchApril
0.38
2.05
SWAV (ShockWave Medical, Inc.)
Benchmark (^GSPC)

Dividends

Dividend History


ShockWave Medical, Inc. doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-50.00%-40.00%-30.00%-20.00%-10.00%0.00%NovemberDecember2024FebruaryMarchApril
-0.20%
-3.92%
SWAV (ShockWave Medical, Inc.)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the ShockWave Medical, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the ShockWave Medical, Inc. was 64.92%, occurring on Mar 20, 2020. Recovery took 115 trading sessions.

The current ShockWave Medical, Inc. drawdown is 0.20%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-64.92%Jun 11, 2019197Mar 20, 2020115Sep 2, 2020312
-52.07%Nov 5, 2021127May 9, 202263Aug 9, 2022190
-48.16%Aug 26, 2022305Nov 10, 202392Mar 26, 2024397
-34.72%Jan 20, 202133Mar 8, 202131Apr 21, 202164
-21.97%Mar 18, 201918Apr 10, 201910Apr 25, 201928

Volatility

Volatility Chart

The current ShockWave Medical, Inc. volatility is 3.57%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


0.00%5.00%10.00%15.00%20.00%25.00%NovemberDecember2024FebruaryMarchApril
3.57%
3.60%
SWAV (ShockWave Medical, Inc.)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of ShockWave Medical, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Income Statement


Income Statement
Balance Sheet
Cash Flow
Annual
Quarterly

TTM
Revenue

Total Revenue

0.00

Cost Of Revenue

0.00

Gross Profit

0.00
Operating Expenses

Selling, General & Admin Expenses

0.00

R&D Expenses

0.00

Total Operating Expenses

0.00
Income

Income Before Tax

0.00

Operating Income

0.00

EBIT

0.00

Earnings From Continuing Operations

0.00

Net Income

0.00

Income Tax Expense

0.00

Interest Expense

0.00

Other Non-Operating Income (Expenses)

0.00

Extraordinary Items

0.00

Discontinued Operations

0.00

Effect Of Accounting Charges

0.00

Non Recurring

0.00

Minority Interest

0.00

Other Items

0.00
Values in undefined except per share items